Calumet, Inc. (CLMT)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Calumet, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 44.20 $ — 100% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -4.1% failed
- More than 10% revenue growth is expected for the coming year 5.0% failed
- Share count grows by less than 3% a year 3.0% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 0.1% failed
- Gross margin at 40% or higher and without meaningful erosion 5.9% failed
- Goodwill from acquisitions does not grow faster than revenue 5.2% passed
- Net debt below twice EBITDA 9.8 x EBITDA failed
- Operating cash flow covers the profits of the last three years 255 m passed
- Return on capital at 15% or higher, or up versus two years ago 2.9% failed
- Insiders hold at least 10% or are net buyers 20.3% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 10.4% below the current price.
- Consensus
- Sell
- Analyst Ratings
- 7
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -2.84 | -2.84 – -2.84 | 4,583 | -500.3% | 1 |
| 12/31/2027 | 0.42 | 0.42 – 0.42 | 4,810 | 114.8% | 1 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.23 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.47 | – | 950 | -2.80 | -4.30 | -3 | -28 |
| 2025: Q1 | -1.87 | – | 994 | -12.30 | -16.30 | -111 | -128 |
| 2025: Q2 | -1.70 | – | 1,027 | -9.40 | -14.40 | 3 | -11 |
| 2025: Q3 | 3.61 | – | 1,078 | -2.00 | 29.10 | 100 | 92 |
| 2025: Q4 | -0.43 | – | 1,039 | 9.40 | -3.60 | 117 | 104 |
| 2026: Q1 | -3.64 | – | 1,030 | 3.60 | -30.80 | -86 | -99 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 3,599 | -40 | -329 | -4.27 | 4 | 219 | 2,725 |
| 2017 | 3,764 | 158 | -104 | -1.34 | -27 | 120 | 2,689 |
| 2018 | 3,498 | 123 | -55 | -0.71 | 75 | -9 | 2,088 |
| 2019 | 3,453 | 76 | -44 | -0.56 | 192 | 10 | 1,858 |
| 2020 | 2,268 | -72 | -149 | -1.90 | 63 | -138 | 1,808 |
| 2021 | 3,148 | -86 | -255 | -3.23 | -44 | -389 | 2,128 |
| 2022 | 4,686 | 132 | -170 | -2.14 | 101 | -534 | 2,741 |
| 2023 | 4,181 | 267 | 48 | 0.60 | -15 | -492 | 2,751 |
| 2024 | 4,189 | 8 | -222 | -2.67 | -46 | -713 | 2,758 |
| 2025 | 4,137 | 54 | -34 | -0.39 | 109 | -733 | 2,689 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Calumet, Inc. fertigt, formuliert und vermarktet ein Sortiment spezialisierter Markenprodukte und erneuerbarer Kraftstoffe in Nordamerika und international.
| Employees | 1,540 |
|---|---|
| Headquarters | Indianapolis, IN |
| Address | 1060 N Capitol Ave., 46204-1044 Indianapolis, United States |
| Phone | 317 328 5660 |
| Website | calumet.com |
| IPO Date | 26. Jan 2006 |
| ISIN | US1314761032 |
| Stock Split | 1:1 on 07/11/2024 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Louis Todd Borgmann | President, CEO & Director | 1983 |
| David A. Lunin | Executive VP & CFO | 1981 |
| Gregory J. Morical | Senior VP, General Counsel & Secretary | 1969 |
| Bruce A. Fleming Ph.D. | Executive Vice President of Montana Renewables & Corporate Development | 1957 |
| Scott Obermeier | President of Specialties | 1973 |
| John Robert Krutz | Chief Accounting Officer | 1976 |
| John Kompa | Director of Investor Relations | – |
| Chris Hodges | Alpha IR | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 9. Jul 2026 | Boss John G. | Director | Other | 2,827 | 0.00 | – |
| 9. Jul 2026 | Boss John G. | Director | Other | 7,067 | 0.00 | – |
| 9. Jul 2026 | Mawer Stephen P | Director | Other | 5,512 | 0.00 | – |
| 9. Jul 2026 | Mawer Stephen P | Director | Other | 13,780 | 0.00 | – |
| 9. Jul 2026 | Raymond Paul C | Director | Other | 2,827 | 0.00 | – |
| 9. Jul 2026 | Raymond Paul C | Director | Other | 7,067 | 0.00 | – |
| 9. Jul 2026 | Sajkowski Daniel J | Director | Other | 2,827 | 0.00 | – |
| 9. Jul 2026 | Sajkowski Daniel J | Director | Other | 7,067 | 0.00 | – |
| 9. Jul 2026 | Schumacher Amy M | Director | Other | 7,067 | 0.00 | – |
| 9. Jul 2026 | Quintana Julio M | Director | Other | 7,067 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.